Back to Elevai Labs
(Nasdaq: ELAB)
Company Info
Overview
Management
FAQ
News
Media
Press Releases
Stock Data
SEC Filings
Governance
Contact
Investors
We rely on the capital markets for the growth of our brands.
View Stock Data
Investor Materials
Investor Presentation
Upcoming Events
Latest Press Releases
View All
November 14, 2024
Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update
November 4, 2024
Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange
October 22, 2024
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity
Latest Filings
10-Q
Quarterly report [Sections 13 or 15(d)]
SC 13G
Statement of Beneficial Ownership by Certain Investors
8-K
Current report
View All
Track all markets on TradingView
